LYMPHOMA, T-CELL, PERIPHERAL

Clinical trials for LYMPHOMA, T-CELL, PERIPHERAL explained in plain language.

Never miss a new study

Get alerted when new LYMPHOMA, T-CELL, PERIPHERAL trials appear

Sign up with your email to follow new studies for LYMPHOMA, T-CELL, PERIPHERAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1 Terminated 1

First-in-Human trial tests experimental drug for Tough-to-Treat blood cancers

Disease control Ongoing

This is the first study testing a new experimental drug called PF-08046044/SGN-35C in people with advanced lymphoma that has returned or stopped responding to standard treatments. The trial will enroll 57 adults with specific types of lymphoma to determine the safest dose, unders…

Matched conditions: LYMPHOMA, T-CELL, PERIPHERAL

Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

LYMPHOMA, T-CELL, PERIPHERAL

Get alerted when new LYMPHOMA, T-CELL, PERIPHERAL trials appear

First-in-Human trial tests experimental drug for Tough-to-Treat blood cancers